Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma
Stem Cell Reviews and Reports · 2025
DOI: 10.1007/s12015-024-10797-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cell Reviews and Reports, 2025. Verfasst von Manar A Elhinnawi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Pathology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Carcinoma, Hepatocellular, Liver Neoplasms, Mitochondria. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is the predominant form of liver cancer and is recognized as a major contributor to cancer-related mortality worldwide. Cancer stem cells (CSCs) are a tiny group of cancer cells that possess a significant ability to regenerate themselves, form tumors, and undergo differentiation. CSCs have a pivotal role in the initiation, spread, recurrence, and resistance to treatment of cancer. As a result, they are very susceptible to being targeted for therapeutic intervention. The potential to cure HCC may be achieved by efficiently targeting drugs that eradicate cancer stem cells. Mitochondria have a crucial function in granting drug resistance to cancer stem cells by means of mitochondrial metabolism, biogenesis, and dynamics. Dysfunction in mitochondrial metabolic processes, such as mitochondrial oxidative phosphorylation (OXPHOS), calcium signaling, and reactive oxygen species (ROS) generation, contributes to the initiation and progression of human malignancies, including HCC. ROS have both beneficial and detrimental effects depending on their concentration. Consequently, ROS have become a prominent subject in the study of the fundamental mechanisms of HCC. Furthermore, an imbalance in the process of creating new mitochondria is a characteristic feature of CSCs, and an increase in mitochondrial biogenesis is associated with the heightened resistance observed in CSCs. This article provides a detailed examination of the involvement of mitochondria in the preservation of CSCs, as well as the spread of HCC. A deeper understanding of how mitochondria participate in tumorigenesis and drug resistance could result in the discovery of novel cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Pathology, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
- Hormones Department, Medical Research and Clinical Studies Institute, National Research Centre, Dokki, Giza, Egypt.
- Biotechnology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.
- Zoology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt. ikasem@sci.cu.edu.eg.
ORCID-Profile: Manar A Elhinnawi, Islam Ahmed Abdelmawgood
Zitieren
APA
Elhinnawi, M. A., Boushra, M. I., Hussien, D. M., Hussein, F. H., & Abdelmawgood, I. A. (2025). Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-024-10797-1
Vancouver
Elhinnawi MA, Boushra MI, Hussien DM, Hussein FH, Abdelmawgood IA. Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma. Stem Cell Reviews and Reports. 2025. doi:10.1007/s12015-024-10797-1
BibTeX
@article{Elhinnawi2025,
author = {Elhinnawi, Manar A and Boushra, Michael Ibrahim and Hussien, Donia Mohamed and Hussein, Fatema Hesham and Abdelmawgood, Islam Ahmed},
title = {Mitochondria’s Role in the Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma},
journal = {Stem Cell Reviews and Reports},
year = {2025},
doi = {10.1007/s12015-024-10797-1}
}
EUVIMED